IMO, investors are still deciding whether Seqirus will be a drain on the overall business to begin to crimp the growth numbers. The Seqirus loss was at the high end of guidance, which is a concern for some.
I am happy to hold. I have enough in my portfolio, and the new product pipeline is hard to beat.
HT1
csl, page-2
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$286.34 |
Change
4.720(1.68%) |
Mkt cap ! $138.6B | |||
| Open | High | Low | Value | Volume |
| $284.00 | $287.00 | $283.05 | $101.2M | 354.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1188 | $286.34 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $286.37 | 1168 | 1 |
View Market Depth
| Last trade - 16.10pm 04/11/2024 (20 minute delay) ? |
| CSL (ASX) Chart |